Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(45)
•••
Post by EduardoSanchezon Apr 15, 2020 9:45am
109 Views
Post# 30911114

Covid Diagnostic Nightmare Continues

Covid Diagnostic Nightmare Continues

The Covid diagnostic nightmare continues! More issues with inaccurate tests. This time it is antibody tests. All these companies coming out of the woodwork and trying to capitalize on the outbreak. Governments that are not remotely prepared for a pandemic and are desperate, this combination creates an absolute mess! Testing for a highly contagious needs to be lab quality, close does not work. Surely, the spotlight will be shifting towards high quality solutions and hopefully scrutinizing of every new solution that comes out daily.

 

Prominent scientists have bad news for the White House about coronavirus antibody tests

By Elizabeth Cohen, Senior Medical Correspondent

Updated 10:32 PM ET, Tue April 14, https://www.cnn.com/2020/04/14/health/coronavirus-antibody-tests-scientists/index.html

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities